Cargando…
Evaluation of vaccination herd immunity effects for anogenital warts in a low coverage setting with human papillomavirus vaccine—an interrupted time series analysis from 2005 to 2010 using health insurance data
BACKGROUND: Shortly after the human papillomavirus (HPV) vaccine recommendation and hence the reimbursement of vaccination costs for the respective age groups in Germany in 2007, changes in the incidence of anogenital warts (AGWs) were observed, but it was not clear at what level the incidence would...
Autores principales: | Thöne, Kathrin, Horn, Johannes, Mikolajczyk, Rafael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5557251/ https://www.ncbi.nlm.nih.gov/pubmed/28806926 http://dx.doi.org/10.1186/s12879-017-2663-7 |
Ejemplares similares
-
Determinants of high-risk human papillomavirus infection in anogenital warts
por: Ozaydin-Yavuz, Goknur, et al.
Publicado: (2019) -
Viral metagenomics updated the prevalence of human papillomavirus types in anogenital warts
por: Xu, Hui, et al.
Publicado: (2019) -
Wide Spectrum Analysis of Human Papillomavirus Genotypes in External Anogenital Warts
por: Rideg, Orsolya, et al.
Publicado: (2021) -
Trends in anogenital wart incidence among Tennessee Medicaid enrollees, 2006–2014: The impact of human papillomavirus vaccination
por: Shing, Jaimie Z., et al.
Publicado: (2019) -
2013 Trends in anogenital warts incidence: Potential impact of human papillomavirus vaccination, TennCare 2006–2015
por: Shing, Jaimie Z., et al.
Publicado: (2018)